MET and neoplasm: In the context of gastric cancer, novel bispecific antibodies such as PD-1/c-Met DVD-Ig and IgG-scFv have been developed to target PD-1 and c-Met, leading to restoration of T-cell function, suppression of tumor growth, and promising implications for the treatment of gastric cancer and other malignancies [208].